All MiNDS on the brain
Nature Biotechnology 36, 238 (2018).
doi:10.1038/nbt.4094
Author: Irene Jarchum (Source: Nature Biotechnology)
Source: Nature Biotechnology - March 6, 2018 Category: Biotechnology Authors: Irene Jarchum Tags: News and Views Source Type: research
Research Highlights
Nature Biotechnology 36, 237 (2018).
doi:10.1038/nbt.4092 (Source: Nature Biotechnology)
Source: Nature Biotechnology - March 6, 2018 Category: Biotechnology Tags: News and Views Source Type: research
An archive written in DNA
Nature Biotechnology 36, 236 (2018).
doi:10.1038/nbt.4093
Author: Reinhard Heckel
New research sets a world record in the volume of data stored in and retrieved from DNA. (Source: Nature Biotechnology)
Source: Nature Biotechnology - March 6, 2018 Category: Biotechnology Authors: Reinhard Heckel Tags: News and Views Source Type: research
Smart cancer therapy with DNA origami
Nature Biotechnology 36, 234 (2018).
doi:10.1038/nbt.4095
Author: Ennio Tasciotti
Tumor infarction is achieved through targeted delivery of thrombin by DNA nanorobots. (Source: Nature Biotechnology)
Source: Nature Biotechnology - March 6, 2018 Category: Biotechnology Authors: Ennio Tasciotti Tags: News and Views Source Type: research
Recent patents in DNA sequencing
Nature Biotechnology 36, 233 (2018).
doi:10.1038/nbt.4105 (Source: Nature Biotechnology)
Source: Nature Biotechnology - March 6, 2018 Category: Biotechnology Tags: Feature Source Type: research
The evidence gap
Nature Biotechnology 36, 228 (2018).
doi:10.1038/nbt.4097
Author: Vicki Seyfert-Margolis
Why digitally powered real-world evidence is the fix needed for our broken clinical trials system. (Source: Nature Biotechnology)
Source: Nature Biotechnology - March 6, 2018 Category: Biotechnology Authors: Vicki Seyfert-Margolis Tags: Opinion and Comment Source Type: research
The NIEHS TaRGET II Consortium and environmental epigenomics
Nature Biotechnology 36, 225 (2018).
doi:10.1038/nbt.4099
Authors: Ting Wang, Erica C Pehrsson, Deepak Purushotham, Daofeng Li, Xiaoyu Zhuo, Bo Zhang, Heather A Lawson, Michael A Province, Christopher Krapp, Yemin Lan, Cristian Coarfa, Tiffany A Katz, Wan Yee Tang, Zhibin Wang, Shyam Biswal, Sanjay Rajagopalan, Justin A Colacino, Zing Tsung-Yeh Tsai, Maureen A Sartor, Kari Neier, Dana C Dolinoy, Jayant Pinto, Robert B Hamanaka, Gokhan M Mutlu, Heather B Patisaul, David L Aylor, Gregory E Crawford, Tim Wiltshire, Lisa H Chadwick, Christopher G Duncan, Amanda E Garton, Kimberly A McAllister, Marisa S Bartolomei, Cher...
Source: Nature Biotechnology - March 6, 2018 Category: Biotechnology Authors: Ting Wang Erica C Pehrsson Deepak Purushotham Daofeng Li Xiaoyu Zhuo Bo Zhang Heather A Lawson Michael A Province Christopher Krapp Yemin Lan Cristian Coarfa Tiffany A Katz Wan Yee Tang Zhibin Wang Shyam Biswal Sanjay Rajagopalan Justin A Colacino Zing Ts Tags: Opinion and Comment Source Type: research
First Rounders podcast: Jeffrey Leiden
Nature Biotechnology 36, 224 (2018).
doi:10.1038/nbt.4087 (Source: Nature Biotechnology)
Source: Nature Biotechnology - March 6, 2018 Category: Biotechnology Tags: Bioentrepreneur Source Type: research
The alphabet soup of agreements
Nature Biotechnology 36, 220 (2018).
doi:10.1038/nbt.4088
Authors: Sadhana Chitale, Colm Lawler & Scott Macfarlane
What you need to know about the paperwork your institution requires when disclosing and commercializing your research. (Source: Nature Biotechnology)
Source: Nature Biotechnology - March 6, 2018 Category: Biotechnology Authors: Sadhana Chitale Colm Lawler Scott Macfarlane Tags: Bioentrepreneur Source Type: research
Driving T-cell immunotherapy to solid tumors
Nature Biotechnology 36, 215 (2018).
doi:10.1038/nbt.4090
Author: Ken Garber
T cell receptor (TCR) gene therapy can target the immune system to solid tumors in ways CAR-T cells can't match, but the field is still looking for a clear success. Ken Garber reports. (Source: Nature Biotechnology)
Source: Nature Biotechnology - March 6, 2018 Category: Biotechnology Authors: Ken Garber Tags: News Source Type: research
Around the world in a month
Nature Biotechnology 36, 214 (2018).
doi:10.1038/nbt0318-214b (Source: Nature Biotechnology)
Source: Nature Biotechnology - March 6, 2018 Category: Biotechnology Tags: News Source Type: research
Correction
Nature Biotechnology 36, 214 (2018).
doi:10.1038/nbt0318-214a (Source: Nature Biotechnology)
Source: Nature Biotechnology - March 6, 2018 Category: Biotechnology Tags: Correction Source Type: research
First off-the-shelf mesenchymal stem cell therapy nears European approval
Nature Biotechnology 36, 212 (2018).
doi:10.1038/nbt0318-212a
Author: Cormac Sheridan (Source: Nature Biotechnology)
Source: Nature Biotechnology - March 6, 2018 Category: Biotechnology Authors: Cormac Sheridan Tags: News Source Type: research
FDA makes drug data public
Nature Biotechnology 36, 212 (2018).
doi:10.1038/nbt0318-212b (Source: Nature Biotechnology)
Source: Nature Biotechnology - March 6, 2018 Category: Biotechnology Tags: News Source Type: research
Preprint wipes millions off CRISPR companies' stocks
Nature Biotechnology 36, 211 (2018).
doi:10.1038/nbt0318-211
Author: Eva von Schaper (Source: Nature Biotechnology)
Source: Nature Biotechnology - March 6, 2018 Category: Biotechnology Authors: Eva von Schaper Tags: News Source Type: research
